GM23327
Fibroblast from Skin, Unspecified
Description:
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A
LAMININ, ALPHA-2; LAMA2
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific |
Class |
Congenital Muscle Diseases |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Unspecified
|
Race
|
White
|
Ethnicity
|
IRISH/POLISH
|
Family Member
|
1
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
5.78 |
Passage Frozen |
2 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
LAMA2 |
Chromosomal Location |
6q22-q23 |
Allelic Variant 1 |
; MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT |
Identified Mutation |
2T>C |
|
Gene |
LAMA2 |
Chromosomal Location |
6q22-q23 |
Allelic Variant 2 |
; MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A |
Identified Mutation |
47delG |
Remarks |
Clinically affected; onset of symptoms before 2 years of age; diagnosis made by muscle imaging and biopsy; abnormal MRI/CT scan; held up head and sat without assistance at 6 months; no other milestones achieved as yet; donor subject is a compound heterozygote: one allele has a T>C transition at nucleotide 2 in the LAMA2 gene (c.2T>C) and the second allele has a 1 bp deletion at nucleotide 47 (c.47delG) |
Cumulative PDL at Freeze |
5.8 |
Passage Frozen |
2 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
3% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
10% fetal bovine serum Not inactivated |
Substrate |
None specified |
Supplement |
- |
|
|